Table 1.
Demographics, comorbidities, clinical symptoms, and radiology findings on admission
| All patients (n = 18) | |
|---|---|
| Age, median (range), y | 32 (7‐47) |
| Gender | |
| Male | 12 (67%) |
| Female | 6 (33%) |
| Travel to Wuhan | 15 (83%) |
| Interval between admission to hospital and departure from Wuhan, median (min, max), d | 8 (1,16) |
| Second‐generation cases | 3 (17%) |
| Incubation period, d | 5, 14, 15 |
| Cluster (cases) | 4 (15) |
| Interval from nucleic acid amplification test positive to negative, median (min, max), d | 9 (5, 18) |
| Length of hospital stay, median (min, max), d | 13.5 (8,20) |
| Comorbidities | 5 (28%) |
| Hypertension | 3 (17%) |
| Hyperlipidemia | 1 (6%) |
| Diabetes | 1 (6%) |
| Liver injury | 3 (17%) |
| Polymyositis | 1 (6%) |
| Signs and symptoms | |
| Fever | 3 (17%) |
| Cough | 9 (50%) |
| Expectoration | 6 (33%) |
| Chest tightness | 6 (33%) |
| Fatigue | 3 (17%) |
| Sore throat | 2 (11%) |
| Diarrhoea | 1 (6%) |
| More than one sign or symptom | 10 (56%) |
| Radiology manifestation | |
| Normal | 2 (11%) |
| Unilateral involvement | 6 (33%) |
| Bilateral involvement | 10 (56%) |
| Multiple mottling and ground‐glass opacity | 12 (67%) |